Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
1.550
-0.080 (-4.91%)
At close: Jul 24, 2026, 4:00 PM EDT
1.500
-0.050 (-3.23%)
After-hours: Jul 24, 2026, 7:59 PM EDT
CDIO Revenue
Cardio Diagnostics Holdings had revenue of $2.68K in the quarter ending March 31, 2026, with 185.11% growth. This brings the company's revenue in the last twelve months to $16.57K, down -16.77% year-over-year. In the year 2025, Cardio Diagnostics Holdings had annual revenue of $14.83K, down -57.51%.
Revenue (ttm)
$16.57K
Revenue Growth
-16.77%
P/S Ratio
276.92
Revenue / Employee
$974
Employees
17
Market Cap
4.59M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.83K | -20.07K | -57.51% |
| Dec 31, 2024 | 34.89K | 17.83K | 104.45% |
| Dec 31, 2023 | 17.07K | 16.12K | 1,696.32% |
| Dec 31, 2022 | 950.00 | 49.00 | 5.44% |
| Dec 31, 2021 | 901.00 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bio Green Med Solution | 1.53M |
| AIM ImmunoTech | 94.00K |
| Silo Pharma | 72.10K |
| Alaunos Therapeutics | 3.00K |
| Soligenix | 2.34K |
| Ernexa Therapeutics | 1,000.00 |
CDIO News
- 4 weeks ago - Cardio Diagnostics announces AHP to cover Epi+Gen CHD, PrecisionCHD - TheFly
- 4 weeks ago - Atlas Healthcare Physicians to Cover Cardio Diagnostics' Precision Cardiovascular Medicine Tests Across Its Network - Business Wire
- 2 months ago - Cardio Diagnostics to showcase cardiovascular solutions at four conferences - TheFly
- 2 months ago - Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June - Business Wire
- 2 months ago - IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Meesha Dogan, CEO of Cardio Diagnostics Holdings Inc. - GlobeNewsWire
- 5 months ago - CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026 - Business Wire
- 5 months ago - Cardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026 - Business Wire
- 7 months ago - Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India - Business Wire